Guardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President

Dow Jones

2024/10/01

By Michael Susin

Guardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans.

The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21.

The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall.

The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations.

Write to Michael Susin at michael.susin@wsj.com

(END) Dow Jones Newswires

October 01, 2024 09:24 ET (13:24 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2472373544"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2472373544\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2472373544?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-01 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472373544","market":"other","top_or_hot":-1,"title":"Guardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Michael Susin \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/GHSI\">Guardion Health Sciences</a> on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans. \n</p>\n<p>\n  The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21. \n</p>\n<p>\n  The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall. \n</p>\n<p>\n  The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Michael Susin at michael.susin@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 01, 2024 09:24 ET (13:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-10-01 21:24</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Michael Susin \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/GHSI\">Guardion Health Sciences</a> on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans. \n</p>\n<p>\n  The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21. \n</p>\n<p>\n  The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall. \n</p>\n<p>\n  The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Michael Susin at michael.susin@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 01, 2024 09:24 ET (13:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4183","symbol_name":"個人用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2472373544","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472373544","pubTimestamp":1727789040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Guardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans.The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21.The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall.The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4183":"个人用品"},"translate_title":"Guardion Health Sciences因进入清算而退市；任命临时首席执行官、总裁","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GHSI":1},"content_text":"By Michael Susin \n\n\n \n\n\nGuardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans. \n\n\n  The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21. \n\n\n  The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall. \n\n\n  The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations. \n\n\n \n\n\n  Write to Michael Susin at michael.susin@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 01, 2024 09:24 ET (13:24 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}